Molecular Biology in the Clinicopathologic Assessment of Endometrial Carcinoma Subtypes

By Boyd J.  

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 163-165

Academic Press

Access to resources Recommend Favorite

Proliferating Cell Nuclear Antigen in Endometrial Carcinoma: Pretreatment Identification of High-Risk Patients

By Garzetti G.G.   Ciavattini A.   Goteri G.   de Nictolis M.   Romanini C.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 16-21

Academic Press

Access to resources Recommend Favorite

The Utility of Pretreatment Barium Enema in Women with Endometrial Carcinoma

By Pearl M.L.   Griffen T.   Valea F.A.   Chalas E.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 442-445

Elsevier

Access to resources Recommend Favorite

Low-Risk Endometrial Carcinoma: Assessment of a Treatment Policy Based on Tumor Ploidy and Identification of Additional Prognostic Indicators

By Lim P.   Aquino-Parsons C.F.   Wong F.   Dupuis B.   Phillips D.   Zhou C.   Gilks C.B.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 191-195

Elsevier

Access to resources Recommend Favorite

Risk-Specific Follow-up for Endometrial Carcinoma Patients

By Shumsky A.G.   Brasher P.M.A.   Stuart G.C.E.   Nation J.G.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 379-382

Elsevier

Access to resources Recommend Favorite